Overview
Lynparza is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer. Lynparza may be prescribed in either hormone receptor-positive or -negative cases, depending on previous treatments and other specific factors. Lynparza is also referred to by its drug name, Olaparib.
Lynparza is a targeted therapy in a class of drugs called poly ADP-ribose polymerase (PARP) inhibitors. Lynparza is believed to work by preventing cancer cells from repairing themselves once damaged by chemotherapy.
How do I take it?
Prescribing information states that Lynparza is taken twice daily.
Lynparza comes in tablet and capsule forms.... read more
We never share your personal information with anyone.